Shantha Biotech to raise funds for new unitIllustrative image – not actual.

As part of its expansion plans, Shantha Biotechnics is reportedly planning to raise around Rs.70 crore to set up a multi-product factory at Medchal, around 40 km from Hyderabad.

 

The unit would manufacture biotechnology products, including the hepatitis B vaccine Shanvac and interferon alpha Shanferon. Products such as human insulin and streptokinase are also planned. The unit is being set up to cater to domestic and international demand for the company’s products.

 

The company plans to apply for the US Food and Drug Administration approval so as to cater to the regulated markets.

 

Related news:

 

Shantha Biotechnics inaugurates R&D centre

← All latest storiesBack to top →